In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, and guest Jessica Glennie, CNP, conclude their 2026 EULAR ILD RhAPP Up Series with a review of important new research on rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and progressive pulmonary fibrosis (PPF).

The discussion examines long-term data showing that interstitial lung disease can develop in patients with rheumatoid arthritis despite effective disease control, reinforcing the importance of ongoing screening and pulmonary monitoring. The episode also highlights new findings on an emerging antifibrotic therapy, including its potential to slow lung function decline, reduce respiratory complications, and improve outcomes for patients with autoimmune-related lung disease.

Whether you're a rheumatology provider, advanced practice provider (APP), or other healthcare professional, this episode offers practical insights into identifying patients at risk for ILD, the value of early detection, and advances in the treatment of progressive pulmonary fibrosis.

Stay tuned for new episodes highlighting the Osteoporosis and PsA Abstracts from EULAR 2026. Visit the Content Rheum and RhAPP ACE app for more rheumatology education.